HCV genotype 2 and 3 infections: what is the optimal duration for peginterferon alpha-2b and ribavirin therapy?

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Muir, AJ

Published Date

  • December 2005

Published In

Volume / Issue

  • 2 / 12

Start / End Page

  • 568 - 569

PubMed ID

  • 16327834

Pubmed Central ID

  • 16327834

International Standard Serial Number (ISSN)

  • 1743-4378

Digital Object Identifier (DOI)

  • 10.1038/ncpgasthep0337

Language

  • eng

Conference Location

  • England